Xencor, Inc Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Xencor, Inc stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $996.00K, a 50.45% increase year-over-year.
- Xencor, Inc stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $662.00K, a 28.82% decline year-over-year.
- Xencor, Inc stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $930.00K, a 25.12% decline year-over-year.
- Xencor, Inc stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $1.24M, a 3.76% increase year-over-year.
- Xencor, Inc stock issued during period, value, employee stock purchase plan for fiscal 2025 was $1.29M, a 22.29% decline from fiscal 2024.
- Xencor, Inc stock issued during period, value, employee stock purchase plan for fiscal 2024 was $1.66M, a 16.03% decline from fiscal 2023.
- Xencor, Inc stock issued during period, value, employee stock purchase plan for fiscal 2023 was $1.98M, a 5.50% decline from fiscal 2022.
- Xencor, Inc stock issued during period, value, employee stock purchase plan for fiscal 2022 was $2.09M, a 13.88% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $996.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $1.29M 10-K · filed 2026-02-25 | |
| 2025-06-30 | $662.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $1.66M 10-K · filed 2026-02-25 | |
| 2024-06-30 | $930.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $1.98M 10-K · filed 2026-02-25 | |
| 2023-06-30 | $1.24M 10-Q/A · filed 2025-02-24 | |
| 2022-12-31 | $2.09M 10-K · filed 2025-02-27 | |
| 2022-06-30 | $1.20M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $1.84M 10-K/A · filed 2025-02-24 | |
| 2021-06-30 | $937.00K 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $1.43M 10-K · filed 2023-02-27 | |
| 2020-06-30 | $725.00K 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $1.39M 10-K · filed 2022-02-24 | |
| 2019-06-30 | $734.00K 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $616.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.12M 10-K · filed 2021-02-24 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | |
| 2018-06-30 | $504.00K 10-Q · filed 2019-11-05 | |
| 2017-12-31 | $493.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $936.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | |
| 2016-12-31 | $319.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $545.00K 10-K · filed 2019-02-26 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | |
| 2015-12-31 | $376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $623.00K 10-K · filed 2018-02-28 |
| 2014-12-31 | $307.00K 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |